Lung Neoplasms: all 7,334 studies

Page 44 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Palliative Thoracic ImmunoRTActive, not recruitingNCT03705806
• The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung CancerActive, not recruitingNCT03705546
• Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary ResectionCompletedNCT03704870Phase 2
• Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLCStatus unknownNCT03703596Phase 2
• Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT03700437Not applicable
• RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung CancerTerminatedNCT03699956Phase 3
• Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung CancerWithdrawnNCT03699033Phase 2
• Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC AdenocarcinomaTerminatedNCT03696212Phase 1/2
• Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their CaregiversCompletedNCT03694054Not applicable
• Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）CompletedNCT03693547Phase 2
• Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping MutationStatus unknownNCT03693339Phase 2
• PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic AbnormalitiesStatus unknownNCT03693326Phase 2
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsActive, not recruitingNCT03693014Phase 2
• Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip PlatformStatus unknownNCT03692442
• Microbiome in Lung Cancer and Other MalignanciesCompletedNCT03688347
• Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLCWithdrawnNCT03684967Phase 2
• Pilot Study of High Risk Lung Cancer ScreeningCompletedNCT03683940Not applicable
• RO5126766 for Patients With Advanced KRAS-Mutant Lung CancerCompletedNCT03681483Phase 1
• Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung CancerStatus unknownNCT03679936
• 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
• The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.WithdrawnNCT03678090Phase 2
• Lung Heart Rate VariabilityWithdrawnNCT03674450Not applicable
• Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerCompletedNCT03673657Phase 2
• Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and CisplatinStatus unknownNCT03671538Not applicable
• A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLCStatus unknownNCT03668496Phase 3
• COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.CompletedNCT03667716Phase 1
• A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLCTerminatedNCT03666728Phase 2
• Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer PatientsStatus unknownNCT03664843
• Itraconazole in Non Small Cell Lung CancerStatus unknownNCT03664115Phase 2
• Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung CancerTerminatedNCT03661567Phase 2
• Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerCompletedNCT03659578Phase 2
• Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New BiomarkersCompletedNCT03658460
• Exploring Robotic-assisted Thoracic Surgery for Lung CancerCompletedNCT03658083
• CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung CarcinomaCompletedNCT03656705Phase 1
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
• Dose Individualization of Pemetrexed - IMPROVE-ICompletedNCT03656549Phase 4
• Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 InhibitorsStatus unknownNCT03656094Phase 2
• Dose Individualization of Pemetrexed - IMPROVE-IIICompletedNCT03655834Phase 4
• Dose Individualization of Pemetrexed - IMPROVE-IITerminatedNCT03655821Phase 4
• Screening and Multiple Intervention on Lung EpidemicsActive, not recruitingNCT03654105Phase 2
• First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) MetastasesCompletedNCT03653546Phase 2/3
• Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung CancerCompletedNCT03652857Phase 2
• A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesCompletedNCT03652077Phase 1
• Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung CancerStatus unknownNCT03651219Phase 3
• Exercise Program Among Lung Cancer DyadsCompletedNCT03649737Not applicable
• Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer PatientsCompletedNCT03648151
• GLUT1: A Novel Tool re fl Ecting Proliferative Activity of Lung Neuroendocrine TumorsCompletedNCT03645915
• A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)CompletedNCT03645330
• Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent RadiotherapyStatus unknownNCT03645317Not applicable
• Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung CancerStatus unknownNCT03645252Not applicable
• Lung Cancer Early Diagnosis With Digital Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 YearsCompletedNCT03645018Phase 3
• Study of Smoking Trajectory in Newly Diagnosis Lung Cancer PatientsCompletedNCT03642041
• A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung CancerCompletedNCT03639194Phase 1
• Dendritic Cell Therapy for Brain Metastases From Breast- or Lung CancerStatus unknownNCT03638765Phase 1
• Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingNCT03637816Phase 2/3
• Comparing Palliative Radiotherapy With or Without CarboplatinTerminatedNCT03637335Phase 3
• Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).Status unknownNCT03634826
• Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung CancerCompletedNCT03633006
• First-line Combination Treatment Based on AnlotinibStatus unknownNCT03628521Phase 1
• Immunonutrition to Reduce Toxicities in Non-Small Cell Lung CancerWithdrawnNCT03628144Phase 2
• Daily vs. Non-Daily SBRT for NSCLCTerminatedNCT03624907Not applicable
• Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung CancerStatus unknownNCT03624309Phase 2
• Quantitative Lung Cancer ScreeningWithdrawnNCT03622528
• Exercise Rehabilitation in Veteran Cancer SurvivorsActive, not recruitingNCT03621813Not applicable
• The Feasibility and Advantages of Painless Indwelling Catheter in Uniportal VATS Lobectomy of Lung CancerStatus unknownNCT03621514Not applicable
• 1st Line Durvalumab in PS 2 NSCLC PatientsActive, not recruitingNCT03620669Phase 2
• Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLCStatus unknownNCT03616691Phase 2
• A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung CancerCompletedNCT03616522
• Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung CancerStatus unknownNCT03613753Phase 2
• Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung CancerStatus unknownNCT03613597Phase 2
• Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCActive, not recruitingNCT03611738Phase 1
• Intensified Follow-up of Lung Cancer Using Weekly Questionnaires Via the InternetCompletedNCT03608410Not applicable
• Study of Alkotinib in Patients With Advanced Non Small Cell Lung CancerCompletedNCT03607188Phase 1
• A Real World Study Based on NGS (TRUMPRWS)Status unknownNCT03605602
• Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLCStatus unknownNCT03603262Phase 1
• Phase I Study of the Combination of Anlotinib With GefitinibStatus unknownNCT03602027Not applicable
• High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerStatus unknownNCT03598517Not applicable
• Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current SmokersActive, not recruitingNCT03598309Phase 2
• Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung CancerCompletedNCT03595644Phase 2
• Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT03590054Phase 1
• Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT03589950Phase 2
• Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell LungCompletedNCT03589547Phase 2
• Establishment of a PDT Patient RegistryTerminatedNCT03589456
• Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung CancerStatus unknownNCT03585998Phase 2
• Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial)Status unknownNCT03583723Not applicable
• Venous Thromboembolism in Advanced Lung CancerStatus unknownNCT03581708
• Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03580694Phase 1
• QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung CancerWithdrawnNCT03574649Phase 2
• Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung CancerWithdrawnNCT03574220Early Phase 1
• CTA Expression/Methylation and Response to Pembrolizumab of NSCLC PatientsStatus unknownNCT03571360Phase 2
• Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerStatus unknownNCT03571126Phase 4
• 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary NodulesStatus unknownNCT03568799Not applicable
• A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung CancersActive, not recruitingNCT03567642Phase 1
• National Register Studies in Thoracic SurgeryActive, not recruitingNCT03567538
• Audio Technology To Detect Lung Cancer EarlierStatus unknownNCT03566862
• Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelStatus unknownNCT03566576Not applicable
• 20K Distributed Learning ChallengeCompletedNCT03564457
• Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial ObstructionTerminatedNCT03564054Not applicable
• Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).CompletedNCT03562819
• A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High IncidenceCompletedNCT03560791

← Lung Neoplasms overview